Carl Icahn
Carl Icahn's Portfolio
| Ticker | # of Shares | Price | Value | |
|---|---|---|---|---|
| CVI | 71,198,718 | $67.90 | $4,834,392,953 | |
| CHK | 59,698,689 | $21.67 | $1,293,670,591 | |
| NFLX | 5,541,066 | $228.74 | $1,267,463,437 | |
| FRX | 30,662,005 | $39.23 | $1,202,870,457 | |
| RIG | 20,154,035 | $52.06 | $1,049,219,063 | |
| HLF | 16,966,485 | $47.65 | $808,453,011 | |
| HLF | 16,355,131 | $47.65 | $779,321,993 | |
| FDML | 76,697,804 | $9.42 | $722,493,314 | |
| NUAN | 33,899,274 | $19.21 | $651,205,054 | |
| HAIN | 7,239,963 | $68.44 | $495,503,068 | |
| View Additional Portfolio Information » | ||||
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
-
Top 10 News Items 2/13-2/17: Apple Breaks $500 Level; Greece Awaits Euro Leader Meeting on Bailout; Earnings Move Stocks Sharply
-
Top 10 News Items 8/15-8/19: HP Gets Slammed as Turnaround Hits a Major Snag; Eurobanks in Focus; Fears of 'Double-Dip Recession' Abound
-
Top 10 News Items 2/22-2/25: Crude Cracks the $100/Barrel Level; Latest Q4 GDP Reading Worse-Than-Expected at 2.8%; HP Tumbles on Earnings, Outlook
